Printer Friendly

CNS REPORTS INTENT TO FILE REGISTRATION STATEMENT

 CNS REPORTS INTENT TO FILE REGISTRATION STATEMENT
 MINNEAPOLIS, Feb. 12 /PRNewswire/ -- CNS, Inc. (NASDAQ: CNXS) of


Minneapolis today announced that it intends to file a registration statement with the Securities and Exchange Commission for the public offering by the company of 1.2 million shares of its common stock. Proceeds of the offering are to be used to complete development of company sleep diagnostic products, brain wave monitors and its new BreatheRight(TM) nasal dilator and for general working capital purposes. The offering, which is expected to be complete in April 1992, will be made through an underwriter and only by means of a prospectus.
 CNS designs, manufactures and markets computer-based systems for data compilation and analysis, primarily for the diagnosis of sleep related disorders.
 -0- 2/12/92
 /CONTACT: Daniel E. Cohen of CNS, 612-474-7600/
 (CNXS) CO: CNS, Inc. ST: Minnesota IN: CPR SU: OFR


AL -- MN006 -- 9155 02/12/92 10:34 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 12, 1992
Words:155
Previous Article:CNS REPORTS 1991 ANNUAL SALES AND LOSSES
Next Article:NEWS CORPORATION REPORTS RESULTS FOR THE SECOND QUARTER
Topics:


Related Articles
CNS, INC. TO FILE REGISTRATION STATEMENT
CNS, INC. TO OFFER COMMON STOCK
CYTOTHERAPEUTICS FILES REGISTRATION STATEMENT FOR OFFERING OF 2,000,000 SHARES OF COMMON STOCK
CNS, INC., ANNOUNCES PROPOSED SECONDARY STOCK OFFERING
CYTOTHERAPEUTICS FILES REGISTRATION STATEMENT FOR OFFERING OF 400,000 UNITS
CYTOTHERAPEUTICS FILES REGISTRATION STATEMENT FOR OFFERING OF 1.5 MILLION SHARES OF COMMON STOCK
CNS, INC., ANNOUNCES PROPOSED STOCK OFFERING
CNS, INC., FILES REGISTRATION STATEMENT FOR PROPOSED PUBLIC OFFERING
CONSOLIDATED STORES CORPORATION FILES REGISTRATION STATEMENT WITH THE S.E.C. TO SELL 3.5 MILLION SHARES OF COMMON STOCK
CNS Response Announces Effectiveness of SB-2 Registration Statement.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters